Logo image of AVR

ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Fundamental Analysis

NASDAQ:AVR - Nasdaq - US03675P1021 - Common Stock - Currency: USD

7.56  -0.33 (-4.18%)

After market: 7.56 0 (0%)

Fundamental Rating

1

Taking everything into account, AVR scores 1 out of 10 in our fundamental rating. AVR was compared to 190 industry peers in the Health Care Equipment & Supplies industry. AVR has a bad profitability rating. Also its financial health evaluation is rather negative. AVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AVR had negative earnings in the past year.
AVR had a negative operating cash flow in the past year.
AVR Yearly Net Income VS EBIT VS OCF VS FCFAVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -10M -20M -30M -40M

1.2 Ratios

AVR's Return On Assets of -218.09% is on the low side compared to the rest of the industry. AVR is outperformed by 93.12% of its industry peers.
The Return On Equity of AVR (-1461.24%) is worse than 88.89% of its industry peers.
Industry RankSector Rank
ROA -218.09%
ROE -1461.24%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVR Yearly ROA, ROE, ROICAVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -100 -200 -300

1.3 Margins

The Gross Margin of AVR (32.06%) is worse than 74.07% of its industry peers.
AVR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVR Yearly Profit, Operating, Gross MarginsAVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

AVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AVR remains at a similar level compared to 1 year ago.
AVR has a better debt/assets ratio than last year.
AVR Yearly Shares OutstandingAVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
AVR Yearly Total Debt VS Total AssetsAVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -15.31, we must say that AVR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AVR (-15.31) is worse than 85.71% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that AVR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, AVR is in the better half of the industry, outperforming 67.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -15.31
ROIC/WACCN/A
WACC8.92%
AVR Yearly LT Debt VS Equity VS FCFAVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 10M -10M -20M -30M

2.3 Liquidity

A Current Ratio of 0.93 indicates that AVR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, AVR is doing worse than 89.95% of the companies in the same industry.
A Quick Ratio of 0.90 indicates that AVR may have some problems paying its short term obligations.
AVR has a worse Quick ratio (0.90) than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.9
AVR Yearly Current Assets VS Current LiabilitesAVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for AVR have decreased strongly by -50.58% in the last year.
AVR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.56%.
EPS 1Y (TTM)-50.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-106.38%
Revenue 1Y (TTM)-14.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.38%

3.2 Future

Based on estimates for the next years, AVR will show a decrease in Earnings Per Share. The EPS will decrease by -9.01% on average per year.
The Revenue is expected to grow by 48.55% on average over the next years. This is a very strong growth
EPS Next Y-130.32%
EPS Next 2Y-16.98%
EPS Next 3Y-9.01%
EPS Next 5YN/A
Revenue Next Year8.02%
Revenue Next 2Y16.5%
Revenue Next 3Y48.55%
Revenue Next 5YN/A

3.3 Evolution

AVR Yearly Revenue VS EstimatesAVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2M 4M 6M 8M
AVR Yearly EPS VS EstimatesAVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVR Price Earnings VS Forward Price EarningsAVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVR Per share dataAVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

AVR's earnings are expected to decrease with -9.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.98%
EPS Next 3Y-9.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR (3/7/2025, 8:06:20 PM)

After market: 7.56 0 (0%)

7.56

-0.33 (-4.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.23%
Inst Owner ChangeN/A
Ins Owners7.63%
Ins Owner Change100%
Market Cap272.31M
Analysts80
Price Target16.83 (122.62%)
Short Float %0.19%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 99.57
P/FCF N/A
P/OCF N/A
P/B 86.46
P/tB 94.39
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)-1.75
Fwd EYN/A
FCF(TTM)-1.48
FCFYN/A
OCF(TTM)-1.41
OCFYN/A
SpS0.08
BVpS0.09
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -218.09%
ROE -1461.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.06%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 169.52%
Cap/Sales 86.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.9
Altman-Z -15.31
F-ScoreN/A
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-106.38%
EPS Next Y-130.32%
EPS Next 2Y-16.98%
EPS Next 3Y-9.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.38%
Revenue Next Year8.02%
Revenue Next 2Y16.5%
Revenue Next 3Y48.55%
Revenue Next 5YN/A
EBIT growth 1Y-45.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-48.26%
EBIT Next 3Y-7.03%
EBIT Next 5YN/A
FCF growth 1Y-19.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.73%
OCF growth 3YN/A
OCF growth 5YN/A